EUVIMEDEUVIMED entdecken
Multizentrische Studie

Subcutaneous cardioverter defibrillator implanted intermuscularly in patients with end-stage renal disease requiring hemodialysis: 5-year follow-up

Axel Kloppe, Joachim Winter, Magnus Prull, Assem Aweimer, Ibrahim El-Battrawy, Christoph Hanefeld, Stephen O'Connor, Andreas Mügge, Fabian Schiedat

Journal of Interventional Cardiac Electrophysiology · 2024

DOI: 10.1007/s10840-024-01767-1 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Interventional Cardiac Electrophysiology, 2024. Verfasst von Axel Kloppe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Intensive Medicine and Angiology, Marienhospital Gelsenkirchen, Academic Hospital of the Ruhr University Bochum, Virchowstr…. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Renal Dialysis, Kidney Failure, Chronic, Death, Sudden, Cardiac. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The aim of the present study was to evaluate the long-term safety and effectiveness of the subcutaneous implantable cardioverter defibrillator (S-ICD) when implanted intermuscularly in patients with end-stage renal disease and hemodialysis. METHODS: This study is a retrospective analysis of 21 consecutive patients implanted with S-ICDs at three experienced centers in Germany with comorbid renal insufficiency requiring hemodialysis, as well as being at risk of sudden cardiac death. The S-ICD was placed intermuscularly in all patients. Follow-ups (FUs) were performed every 6 months. RESULTS: The mean ± standard deviation FU duration was 60.0 ± 11.4 months, with a range of 39 to 78 months. There were no deaths due to arrhythmia, or device-associated infections and complications. Four patients (19.1%) died during FU due to respiratory insufficiency during dialysis, systolic heart failure, septic infection of the urogenital tract, and colorectal cancer, respectively. There were six non-device-related hospitalizations with a duration of 12.7 ± 5.1 days and a hospitalization rate of 4.1 per 100 patient years. CONCLUSIONS: In the long-term FU of this small population of seriously compromised hemodialysis patients at risk of sudden cardiac death, the intermuscularly implanted S-ICD system was safe and effective. No arrhythmic complications, device-associated infections, or complications compromised survival. These data are encouraging and support testing in a larger group of similarly compromised patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantableRenal DialysisKidney Failure, ChronicDeath, Sudden, CardiacHumansMaleFemaleRetrospective StudiesMiddle AgedFollow-Up StudiesAgedTreatment OutcomeGermanySurvival Rate

Stichwörter der Autor:innen

Device infectionEnd-stage renal diseaseHemodialysisImplantable cardioverter defibrillatorS-ICDSudden cardiac death

Autor:innen und Institutionen

  • Department of Cardiology, Intensive Medicine and Angiology, Marienhospital Gelsenkirchen, Academic Hospital of the Ruhr University Bochum, Virchowstraße 122, 45886, Gelsenkirchen, Germany.
  • Department of Cardiology and Angiology, University Hospital Bergmannsheil Bochum, Ruhr University Bochum, Bochum, Germany.
  • Department of Cardiovascular Surgery, Heinrich Heine University, Dusseldorf, Germany.
  • Department of Cardiology, Augusta Hospital Bochum, Bochum, Germany.
  • Department of Molecular and Experimental Cardiology, Institut Für Forschung Und Lehre (IFL), Ruhr University Bochum, Bochum, Germany.
  • Department of Cardiology, Katholische Kliniken Bochum, Ruhr University Bochum, Bochum, Germany.

Zitieren

APA

Kloppe, A., Winter, J., Prull, M., Aweimer, A., El-Battrawy, I., Hanefeld, C., O'Connor, S., Mügge, A., & Schiedat, F. (2024). Subcutaneous cardioverter defibrillator implanted intermuscularly in patients with end-stage renal disease requiring hemodialysis: 5-year follow-up. Journal of Interventional Cardiac Electrophysiology. https://doi.org/10.1007/s10840-024-01767-1

Vancouver

Kloppe A, Winter J, Prull M, Aweimer A, El-Battrawy I, Hanefeld C, et al. Subcutaneous cardioverter defibrillator implanted intermuscularly in patients with end-stage renal disease requiring hemodialysis: 5-year follow-up. Journal of Interventional Cardiac Electrophysiology. 2024. doi:10.1007/s10840-024-01767-1

BibTeX
@article{Kloppe2024,
  author = {Kloppe, Axel and Winter, Joachim and Prull, Magnus and Aweimer, Assem and El-Battrawy, Ibrahim and Hanefeld, Christoph and O'Connor, Stephen and Mügge, Andreas and Schiedat, Fabian},
  title = {Subcutaneous cardioverter defibrillator implanted intermuscularly in patients with end-stage renal disease requiring hemodialysis: 5-year follow-up},
  journal = {Journal of Interventional Cardiac Electrophysiology},
  year = {2024},
  doi = {10.1007/s10840-024-01767-1}
}
Kostenlos starten →